Maternal allopurinol administration during suspected fetal hypoxia:A novel neuroprotective intervention? A multicentre randomised placebo controlled trial

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 100, Issue 3, 2015, Pages F216-F223

  Kaandorp, Joepe J ^a   Benders, Manon J N L ^a   Schuit, Ewoud ^a   Rademaker, Carin M A ^a   Oudijk, Martijn A ^a   Porath, Martina M ^b   Oetomo, Sidarto Bambang ^b   Wouters, Maurice G A J ^c   Van Elburg, Ruurd M ^c,d   Franssen, Maureen T M ^e   Bos, Arie F ^e   De Haan, Timo R ^f   Boon, Janine ^g   De Boer, Inge P ^g   Rijnders, Robbert J P ^h   Jacobs, Corrie J W F M ^h   Scheepers, Liesbeth H C J ⁱ   Gavilanes, Danilo A W ⁱ   Bloemenkamp, Kitty W M ^j   Rijken, Monique ^j   Van Meir, Claudia A ^k   Von Lindern Anjoke J M Huisjes Saskia C M J E R Bakker, Jeannette S ^k,l   Mol, Ben W J ^e   Visser, Gerard H A ^a   Van Bel, Frank ^a   Derks, Jan B ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d DANONE RESEARCH   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g DEPARTMENT OF SURGERY   (Netherlands)

^h JEROEN BOSCH HOSPITAL   (Netherlands)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k GROENE HART HOSPITAL   (Netherlands)

^l GELRE HOSPITALS   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ALLOPURINOL; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ISOPROSTANE DERIVATIVE; NEUROPROSTANE; PLACEBO; PROTEIN S100B; 8-EPI-PROSTAGLANDIN F2ALPHA; ALDEHYDE; ENZYME INHIBITOR; KETONE; OXIPURINOL; PROSTAGLANDIN F2 ALPHA; S100B PROTEIN, HUMAN; XANTHINE OXIDASE;

ADULT; ANAPHYLACTIC SHOCK; BRAIN DAMAGE; BRAIN TISSUE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DELIVERY ROOM; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FETUS HYPOXIA; HIGH RISK INFANT; HUMAN; INFANT; INTERVENTION STUDY; LABOR INDUCTION; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; MATERNAL TREATMENT; NEUROPROTECTION; NEWBORN; NEWBORN DISEASE; OUTCOME ASSESSMENT; POSTPARTUM HEMORRHAGE; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEX DIFFERENCE; UMBILICAL CORD BLOOD; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMISTRY; CLINICAL TRIAL; FETAL HYPOXIA; FETOMATERNAL TRANSFUSION; FETUS BLOOD; MULTICENTER STUDY; PREGNANCY;

ADULT; ALDEHYDES; ALLOPURINOL; DINOPROST; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; FETAL BLOOD; FETAL HYPOXIA; HUMANS; KETONES; MALE; MATERNAL-FETAL EXCHANGE; OXYPURINOL; PREGNANCY; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; XANTHINE OXIDASE;

EID: 84927759046     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2014-306769     Document Type: Conference Paper

References (36)

1. Low JA. Determining the contribution of asphyxia to brain damage in the neonate. J Obstet Gynaecol Res 2004;30:276-86.
2. Rosenberg AA, Murdaugh E, White CW. The role of oxygen free radicals in postasphyxia cerebral hypoperfusion in newborn lambs. Pediatr Res 1989;26:215-9.
3. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet 2005;365:663-70.
4. Jacobs SE, Berg M, Hunt R, et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013;1:CD003311.
5. Palmer C, Vannucci RC, Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 1990;27(4 Pt 1):332-6.
6. Kaandorp JJ, van den Broek MP, Benders MJ, et al. Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour. Arch Dis Child Fetal Neonatal Ed 2014;99:F144-8.
7. Palmer C, Towfighi J, Roberts RL, et al. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993; 33(4 Pt 1):405-11.
8. Benders MJ, Bos AF, Rademaker CM, et al. Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia. Arch Dis Child Fetal Neonatal Ed 2006;91:F163-5.
9. Van Bel F, Shadid M, Moison RM, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;101:185-93.
10. Derks JB, Oudijk MA, Torrance HL, et al. Allopurinol reduces oxidative stress in the ovine fetal cardiovascular system after repeated episodes of ischemia-reperfusion. Pediatr Res 2010;68:374-80.
11. Kaandorp JJ, Derks JB, Oudijk MA, et al. Antenatal allopurinol reduces hippocampal brain damage after acute birth asphyxia in late gestation fetal sheep. Reprod Sci 2014;21:251-9.
12. Torrance HL, Benders MJ, Derks JB, et al . Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 2009;124:350-7.
13. FIGO News. Guidelines for the use of fetal monitoring. Int J Gynecol Obstet 1987;25:159-67.
14. Amer-Wahlin I, Arulkumaran S, Hagberg H, et al. Fetal electrocardiogram: ST waveform analysis in intrapartum surveillance. BJOG 2007;114:1191-3.
15. Boda D, Németh P, Kiss P, et al. Treatment of mothers with allopurinol to produce therapeutic blood levels in newborns. Prenat Neonat Med 1999;4:130-2, 133, 134.
16. Summary of product characteristics acepurin® . http://db.cbg-meb.nl/Bijsluiters/ h09974.pdf. Updated 2012.
17. Gazzolo D, Visser GH, Lituania M, et al. S100B protein cord blood levels and development of fetal behavioral states: A study in normal and small-for-dates fetuses. J Matern Fetal Neonatal Med 2002;11:378-84.
18. Michetti F, Corvino V, Geloso MC, et al. The S100B protein in biological fluids: More than a lifelong biomarker of brain distress. J Neurochem 2012;120:644-59.
19. Beharier O, Kahn J, Shusterman E, et al. S100B-a potential biomarker for early detection of neonatal brain damage following asphyxia. J Matern Fetal Neonatal Med 2012;25:1523-8.
20. Bernoud-Hubac N, Davies SS, Boutaud O, et al. Formation of highly reactive gamma-ketoaldehydes (neuroketals) as products of the neuroprostane pathway. J Biol Chem 2001;276:30964-70.
21. Rogers MS, Wang CC, Lau TK, et al. Relationship between isoprostane concentrations, metabolic acidosis, and morbid neonatal outcome. Clin Chem 2005;51:1271-4.
22. Seet RC, Lee CY, Chan BP, et al. Oxidative damage in ischemic stroke revealed using multiple biomarkers. Stroke 2011;42:2326-9.
23. van Kesteren C, Benders MJ, Groenendaal F, et al. Population pharmacokinetics of allopurinol in full-term neonates with perinatal asphyxia. Ther Drug Monit 2006;28:339-44.
24. Kane AD, Camm EJ, Richter HG, et al . Maternal-to-fetal allopurinol transfer and xanthine oxidase suppression in the late gestation pregnant rat. Physiol Rep 2013;1:e00156.
25. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
26. McGreevy KM, Lipsitz SR, Linder JA, et al. Using median regression to obtain adjusted estimates of central tendency for skewed laboratory and epidemiologic data. Clin Chem 2009;55:165-9.
27. Geraci M. Linear quantile mixed models: The lqmm package for laplace quantile regression. J Stat Software 2014;57:1-29.
28. Nijboer CH, Kavelaars A, van Bel F, et al. Gender-dependent pathways of hypoxia-ischemia-induced cell death and neuroprotection in the immature P3 rat. Dev Neurosci 2007;29:385-92.
29. Wen Y, Yang S, Liu R, et al. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res 2004;1008:147-54.
30. Renolleau S, Fau S, Charriaut-Marlangue C. Gender-related differences in apoptotic pathways after neonatal cerebral ischemia. Neuroscientist 2008;14:46-52.
31. Spence RD, Hamby ME, Umeda E, et al. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 2011; 108:8867-72.
32. Hurn PD, Vannucci SJ, Hagberg H. Adult or perinatal brain injury: does sex matter? Stroke 2005;36:193-5.
33. Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine. Clin Chem 2002;48:2097-104.
34. Nagdyman N, Komen W, Ko HK, et al. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res 2001;49:502-6.
35. Kaandorp JJ, van Bel F, Veen S, et al. Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: Follow-up of two randomised controlled trials. Arch Dis Child Fetal Neonatal Ed 2012;97:F162-6.
36. Marro PJ, Hoffman D, Schneiderman R, et al. Effect of allopurinol on NMDA receptor modification following recurrent asphyxia in newborn piglets. Brain Res 1998;787:71-7.